Cannabis Confidential

Cannabis Confidential

Share this post

Cannabis Confidential
Cannabis Confidential
Kidney Stoners

Kidney Stoners

Cannaland waits for the pain to pass.

Todd Harrison's avatar
Todd Harrison
Oct 18, 2024
∙ Paid
2

Share this post

Cannabis Confidential
Cannabis Confidential
Kidney Stoners
Share

Daily Recap

Ten Republican governors are arguing before the U.S. Supreme Court that the “flexibility” states have generally been afforded to legalize marijuana in spite of federal prohibition is an example of why they should also have the right to ban gender-affirming medical care for youth.

Yellow Brick Road

As Kansas lawmakers once again take up the issue of marijuana reform, a top state regulator is advising that it would be “easier to implement” recreational legalization first, rather than start with a medical cannabis program as other states have done.

California Dreaming

During a statewide enforcement crackdown on intoxicating hemp products, the California seized more than 700 products banned under recently enacted rules. Agents inspected 383 establishments as part of the effort. ABC Director Joseph McCullough told FOX 26 that “97% were in compliance with the new regulations.”

Maple Leaves

Cannabis sales in Ontario, Canada, surged during the first half of the year, with licensed retailers selling 21% more marijuana by volume than they did during the same period last year.

Stocks & Stuff

It was a quiet October expiration in Cannaland as the space awaits further clarity and traders await volumes and/ or higher prices, in no particular order. U.S. cannabis ETF MSOS finished flattish on a paltry $47M in total notional volume.

Below, we’ll top-line the landscape, revisit a former life, check the Florida polling, peek into the Pennsylvania particulars, eyeball sector multiples and spy global growth.

All that and more, just scroll down.

SPY 0.00%↑ QQQ 0.00%↑ IWM 0.00%↑ MSOS 0.00%↑ ETF Notional: $47M

Top Stories

Keep reading with a 7-day free trial

Subscribe to Cannabis Confidential to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Todd Harrison
Market data by Intrinio
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share